Is maintenance chemotherapy always necessary in gestational trophoblastic neoplasia? A retrospective cohort analysis

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Retrospective cohort analysis reveals maintenance chemotherapy may not be needed for low-risk GTN patients, suggesting individualized care is vital.

Maintenance chemotherapy did not prevent relapse in high-risk patients, indicating potential over-treatment.
Among 25 patients, only 8% showed methotrexate resistance, underscoring the efficacy of primary therapy.
FIGO staging provided limited prognostic discrimination, advocating for alternative risk stratification approaches.
Real-world data emphasizes the importance of individualized treatment strategies based on patient response.

Hafızoğlu et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Retrospective cohort analysis reveals maintenance chemotherapy may not be needed for low-risk GTN patients, suggesting individualized care is vital.